Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Understanding molecular mechanism of diabetic wound healing: addressing recent advancements in therapeutic managements

Porel P., Kaur M., Sharma V., Aran KR.

Narrative Review on Diabetic Foot, Chronic Wound, Chronic Inflammation, published in J Diabetes Metab Disord (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Diabetes Metab Disord (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40060271
PMCID
PMC11883079
DOI
10.1007/s40200-025-01588-7
Citations
10

Abstract (original English)

Diabetes mellitus (DM) is a common but complicated metabolic disease that causes hyperglycemia for a long time. It may cause serious health problems, such as poor wound healing. The complex biology of diabetic wound healing is reviewed here, with particular attention paid to the interactions between neuropathy, inadequate angiogenesis, metabolic dysfunctions, and chronic inflammation. Diabetes affects approximately 537 million individuals globally, and as the disease becomes more common, new treatment methods for chronic wounds are required. Reduced blood flow, sensory loss, and an insufficient inflammatory response are some of the variables that combine to cause persistent diabetes ulcers and often impede the healing process. There is major health issues associated with these ulcers, such as infections, gangrene formations, and even limb loss. Recent developments in the molecular processes of diabetic wound healing have provided important new information on the function of metabolic imbalances, the dysregulation of inflammatory pathways, and polymicrobial infections in tissue repair. This article discusses contemporary therapy strategies, which range from traditional wound care procedures to cutting-edge interventions including growth factor therapies and bioengineered skin replacements. To improve wound healing in diabetes patients, we want to provide researchers and physicia

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research